MultiOmic Health

Startup

MultiOmic Health is an AI-enabled drug discovery startup dedicated to developing precision therapeutics for conditions related to metabolic syndrome. Our current focus is on complications arising from type 2 diabetes, such as diabetic kidney disease. We work with research institutions, healthcare providers, and healthtech companies to gain access to de-identified patient data and bio-samples. Our proprietary MOHSAIC® platform then integrates multi-omics analysis and computational systems biology modelling to identify patient endotypes and causal pathways. As we continue to originate precision treatment concepts, we will confirm biomarkers and establish causal pathway inference in patient subpopulations through targeted wet lab experimentation.